Q3 2015 13F Holders as of 30 Sep 2015
-
Type / Class
-
Equity / COM NEW
-
Total 13F shares
-
3,471,372
-
Share change
-
-2,614,780
-
Total reported value
-
$9,586,000
-
Price per share
-
$2.76
-
Number of holders
-
46
-
Value change
-
-$6,419,347
-
Number of buys
-
17
-
Number of sells
-
36
Institutional Holders of OHR PHARMACEUTICAL INC - COM NEW (OHRP) as of Q3 2015
As of 30 Sep 2015,
OHR PHARMACEUTICAL INC - COM NEW (OHRP) was held by
46 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
3,471,372 shares.
The largest 10 holders included
VANGUARD GROUP INC, BlackRock Institutional Trust Company, N.A., BAKER BROS. ADVISORS LP, SUSQUEHANNA INTERNATIONAL GROUP, LLP, Knoll Capital Management, LP, GEODE CAPITAL MANAGEMENT, LLC, STONERIDGE INVESTMENT PARTNERS LLC, PNC Financial Services Group, Inc., GARRISON BRADFORD & ASSOCIATES INC, and Hoxton Financial, Inc..
This page lists
46
institutional shareholders reporting positions in this security
for the Q3 2015 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.